Patents for C12P 21 - Preparation of peptides or proteins (112,499)
06/2006
06/15/2006US20060127959 Antibodies that bind M. tuberculosis polypeptides
06/15/2006US20060127950 Methods and products related to the improved analysis of carbohydrates
06/15/2006US20060127937 Novel Survivin interacting protein TPR1
06/15/2006US20060127927 Mammalian IAP gene family, primers, probes, and detection methods
06/15/2006US20060127923 Internal ribosomal entry site mediated gene expression
06/15/2006US20060127921 PECAM-1-related molecules compositions kit of parts and associated methods of use
06/15/2006US20060127914 Nicotinic acetylcholine receptor
06/15/2006US20060127913 Alternatively spliced isoforms of human PHKA2
06/15/2006US20060127903 Marker for cancer
06/15/2006US20060127899 Active carbohydrate containing protecting reagents for chemical modifications, their production and use
06/15/2006US20060127897 Delete sequence in m, tuberculosis, method for detecting mycobacteria using these sequences and vaccines
06/15/2006US20060127894 Protein associated with cell growth, differentiation, and death
06/15/2006US20060127893 Modification of human variable domains
06/15/2006US20060127890 Novel gene overexpressed in heart and skeletal muscle and use thereof
06/15/2006US20060127877 Fluorescent protein
06/15/2006US20060127489 Targeted delivery
06/15/2006US20060127447 Poly-gamma-glutamate having ultra high molecular weight and method for using the same
06/15/2006US20060127416 Polynucleotide encoding a protein believed to be highly immunogenic, especially in fish, and also has utility as a non-specific adjuvant, and as an adjuvanting carrier for heterologous antigens.
06/15/2006US20060127411 Immune -modulating peptide made of s.aureus enterotoxin b
06/15/2006US20060127408 Cancer immunotherapy
06/15/2006US20060127405 Specifically recognizing human oculospanin and having cytotoxic activity against cancer cells, cancer therapy
06/15/2006US20060127400 Activation of regulatory T cells by alpha-melanocyte stimulating hormone
06/15/2006US20060127394 Cloning of honey bee allergen
06/15/2006US20060127393 antibodies and antigen binding domains and CDR regions that mediate selective binding to an epitope located in the carboxyl half of the Dkk-1 protein; for bone disorders, inflammatory, neurological, ocular, renal, pulmonary and skin diseases
06/15/2006US20060127389 Fused protein with the function of both hemolysis and anticoagulation and use of it
06/15/2006US20060127388 Variants of glycogen synthase kinase 3 and uses thereof
06/15/2006US20060127371 ASB transcription repressor proteins and nucleic acids and their application in expansion of stem cells
06/15/2006US20060127356 Single-stranded polynucleotides that code for human melanoma antigen(MAGE) and human leukocyte antigens, used in gene therapy and medical diagnosis; immunology
06/15/2006US20060127328 Fully active alternansucrases partially deleted in its carboxy-terminal and amino-terminal domains and mutants thereof
06/15/2006US20060127327 Monoclonal antibodies specific for cariogenic bacteria
06/15/2006CA2630088A1 Signal peptides, nucleic acid molecules and methods of treatment
06/15/2006CA2597614A1 Plant proteins having an abscisic acid binding site and methods of use
06/15/2006CA2594151A1 Methods for the production and secretion of modified peptides
06/15/2006CA2593034A1 Compositions and methods based upon the kinase haspin
06/15/2006CA2590284A1 Recombinant method for making multimeric proteins
06/15/2006CA2589937A1 Rhamnose promoter expression system
06/15/2006CA2587143A1 Methods and compositions for immunotherapy and detection of inflammatory and immune-dysregulatory disease, infectious disease, pathologic angiogenesis and cancer
06/14/2006EP1669759A1 Novel high throughput screening method of drug for physiologically active protein
06/14/2006EP1669463A1 Casein hydrolyzate, process for producing the same and use thereof
06/14/2006EP1669453A1 Novel nerve stem cell marker
06/14/2006EP1669448A1 Process for producing antigenic substance
06/14/2006EP1668161A2 Fragment complementation assays for g-protein-coupled receptors and their signaling pathways
06/14/2006EP1668146A2 Homogeneous populations of molecules
06/14/2006EP1668136A2 A process for proteolytic cleavage and purification of recombinant proteins produced in plants
06/14/2006EP1668135A2 A non-denaturing process to purify recombinant proteins from plants
06/14/2006EP1668125A2 Modified enzymes, methods to produce modified enzymes and uses thereof
06/14/2006EP1668121A1 Mammalian cell lines modified for the production of recombinant glycoproteins
06/14/2006EP1668114A2 Polypeptide display libraries and methods of making and using thereof
06/14/2006EP1667718A2 Method of promoting graft survival with anti-tissue factor antibodies
06/14/2006EP1667701A2 Tumor vaccine
06/14/2006EP1451367A4 Engineering of leader peptides for the secretion of recombinant proteins in bacteria
06/14/2006EP1438336B1 Compositions of fsh with high sialylation degree and their use for the preparation of medicaments
06/14/2006EP1309861B1 Functional protein arrays
06/14/2006EP1255558B1 Anti-april antibodies and hybridoma cells
06/14/2006EP1200561B1 Recombinant stabile cell clone, its production and use thereof
06/14/2006EP1097210B1 Immunological reagent specifically interacting with the extracellular domain of the human zeta chain
06/14/2006EP1045926B1 Gene family with transformation modulating activity
06/14/2006EP1033373B1 Feline granulocyte colony-stimulating factor
06/14/2006EP0956360B1 Poxvirus-based expression vectors containing heterologous inserts derived from lentiviruses
06/14/2006EP0795605B1 Denatured low-density lipoprotein receptor
06/14/2006EP0777687B1 Trefoil peptide dimer
06/14/2006EP0760867B1 Compositions and methods relating to dna mismatch repair genes
06/14/2006EP0750509B2 USE OF IL-12 AND IL-12 ANTAGONISTS for the manufacture of a pharmaceutical composition for THE TREATMENT OF AUTOIMMUNE DISEASES
06/14/2006EP0723536B2 An aglucone isoflavone enriched vegetable protein whey, and process for producing
06/14/2006EP0699236B2 Purified mammalian flt3 ligands and agonists and antagonists thereof
06/14/2006EP0666868B2 Use of anti-VEGF antibodies for the treatment of cancer
06/14/2006DE102004059357A1 New antibody (which specifically recognizes human thiamine 1) useful for blocking the binding of human Thy-1 at its ligand or for blocking the interaction of tumor cells or immune cells with endothelial cells
06/14/2006CN1788092A Engineering of leader peptides for the secretion of recombinant proteins in bacteria
06/14/2006CN1786183A Technology of preparing bioactive short peptide by high efficiency enzymolysis corn protein
06/14/2006CN1786182A Method of preparing product containing sogabean peptide by microorganism fermentation process
06/14/2006CN1786165A Preparation method of recombination staphylococcus aureus enterotoxin C2
06/14/2006CN1786164A Preparation method of recombination buman tPA
06/14/2006CN1786022A Mermaid luminous bacillus outer membrane protein V and coding sequence, its preparation method and application
06/14/2006CN1259429C Integrated production method of protein fermentation
06/14/2006CN1259337C Synthesis, expression, preparation and application for human parathyroid hormone gene mutant
06/14/2006CN1259333C Separation purification method for preparing sex-gene recombination spider dragline silk protein
06/14/2006CN1259063C Method for preparing non-specific immunity activator
06/13/2006US7060805 Methods for isolating tissue factor inhibitor
06/13/2006US7060802 Monoclonal antibody hybridomas ; detecting cancer
06/13/2006US7060800 Polypeptides for use in the treatment and diagnosis of crohn's disease
06/13/2006US7060799 Detecting preferential antibody in sample; obtain sample which contains preferential epitopes, incubate with antibodies, detect signal
06/13/2006US7060791 Genetic engineering; bone disorders; anticancer agent
06/13/2006US7060790 Genetic engineering; antitumor agents; therapy for microbiocide infections; antiinflammatory agents; immunology
06/13/2006US7060687 Live vaccines for allergy treatment
06/13/2006US7060682 direct interaction with the ligand-bound receptor and activation of one or more transcription factors; unaffected by the presence or concentration of second messengers; direct interaction with tyrosine kinase domains; absence of interaction with G-proteins; transcriptional stimulation of target genes
06/13/2006US7060673 Fusion peptide of human parathyroid hormone derived peptide and tat peptide, preparation thereof, and skin slimming cosmetic composition comprising the same
06/13/2006US7060669 in aqueous two-phase systems by fusing hydrophobin or hydrophobin-like protein to a protein of interest, such as an extracellular protein of Trichoderma, selected from the group consisting of cellulases, hemicellulases and proteases.
06/13/2006US7060497 Adeno-associated viral vector-based methods and compositions for introducing an expression cassette into a cell
06/13/2006US7060495 Polypeptide for use in as anticarcinogenic agent
06/13/2006US7060490 having an N-terminal domain, a DNA-binding domain and a ligand-binding domain
06/13/2006US7060482 Thermostable xylanases
06/13/2006US7060481 Comprises peptide for diagnosing and treating inflammatory, tumor, arthritic and nervous system disorders
06/13/2006US7060480 MRE11 orthologue and uses thereof
06/13/2006US7060479 Full-length human cDNAs encoding potentially secreted proteins
06/13/2006US7060476 Detection modulators of enzyme activity; obtain sample containing enzyme, incubate with binding protein, monitor adjustment in enzyme activity
06/13/2006US7060466 Methods of producing hyaluronic acid using a recombinant hyaluronan synthase gene
06/13/2006US7060465 Modified chitin binding domain and uses thereof
06/13/2006US7060464 Peptides conferring environmental stress resistance and fusion proteins including said peptides
06/13/2006US7060463 DNA molecules encoding Macaca mulatta androgen receptor
06/13/2006US7060462 Agrobacterium tumefaciens outer membrane protein;